My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.

    Dai YD, Marrero IG, Gros P, Zaghouani H, Wicker LS, Sercarz EE.

    Diabetes. 2009 Jan;58(1):156-64. Epub 2008 Nov 4.PMID: 18984740 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function.

    Stober CB, Brode S, White JK, Popoff JF, Blackwell JM.

    Infect Immun. 2007 Oct;75(10):5059-67. Epub 2007 Jul 9.PMID: 17620357 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.

    Leiter EH, Christianson GJ, Serreze DV, Ting AT, Worthen SM.

    J Exp Med. 1989 Oct 1;170(4):1243-62.PMID: 2507727 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.

    J Immunol. 1999 Jul 15;163(2):743-50.PMID: 10395666 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.

    Bodey B, Bodey B Jr, Kaiser HE.

    In Vivo. 1997 Jul-Aug;11(4):351-70.PMID: 9292303 [PubMed - indexed for MEDLINE]Related articles

    6.

    T-cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes.

    Thiessen S, Serra P, Amrani A, Verdaguer J, Santamaria P.

    Diabetes. 2002 Feb;51(2):325-38.PMID: 11812739 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.

    Tian C, Ansari MJ, Paez-Cortez J, Bagley J, Godwin J, Donnarumma M, Sayegh MH, Iacomini J.

    J Immunol. 2007 Nov 15;179(10):6762-9.PMID: 17982066 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response.

    Ridgway WM, Ito H, Fassò M, Yu C, Fathman CG.

    J Exp Med. 1998 Dec 21;188(12):2267-75.PMID: 9858513 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.

    Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P.

    J Autoimmun. 1993 Dec;6(6):753-69.PMID: 8155255 [PubMed - indexed for MEDLINE]Related articles

    10.

    Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

    Chosich N, Harrison LC.

    Diabetologia. 1993 Aug;36(8):716-21.PMID: 8405738 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.

    Stephens LA, Kay TW.

    Int Immunol. 1995 Dec;7(12):1885-95.PMID: 8746558 [PubMed - indexed for MEDLINE]Related articles

    12.

    Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells.

    Greening JE, Tree TI, Kotowicz KT, van Halteren AG, Roep BO, Klein NJ, Peakman M.

    Diabetes. 2003 Mar;52(3):717-25.PMID: 12606513 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.

    Rivereau AS, You S, Lalain S, Gouin E, Saï P.

    Transplantation. 1998 Sep 15;66(5):633-8.PMID: 9753345 [PubMed - indexed for MEDLINE]Related articles

    14.

    Adoptive transfer of islet antigen-autoreactive T cell clones to transgenic NOD.Ea(d)mice induces diabetes indicating a lack of I-E mediated protection against activated effector T cells.

    Roberts SA, Barbour G, Matarrese MR, Mason DL, Leiter EH, Haskins K, Hanson MS.

    J Autoimmun. 2003 Sep;21(2):139-47.PMID: 12935783 [PubMed - indexed for MEDLINE]Related articles

    15.

    Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes.

    Höglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D.

    J Exp Med. 1999 Jan 18;189(2):331-9.PMID: 9892615 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.

    Durinovic-Belló I.

    Autoimmunity. 1998;27(3):159-77. Review.PMID: 9609134 [PubMed - indexed for MEDLINE]Related articles

    17.

    IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.

    Falcone M, Yeung B, Tucker L, Rodriguez E, Krahl T, Sarvetnick N.

    Clin Immunol. 2001 Feb;98(2):190-9.PMID: 11161975 [PubMed - indexed for MEDLINE]Related articles

    18.

    Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens.

    Yamanouchi J, Verdaguer J, Han B, Amrani A, Serra P, Santamaria P.

    J Immunol. 2003 Dec 15;171(12):6900-9.PMID: 14662897 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens.

    Green EA, Eynon EE, Flavell RA.

    Immunity. 1998 Nov;9(5):733-43.PMID: 9846494 [PubMed - indexed for MEDLINE]Related articles

    20.

    Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.

    Gaudreau S, Guindi C, Ménard M, Besin G, Dupuis G, Amrani A.

    J Immunol. 2007 Sep 15;179(6):3638-47.PMID: 17785799 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity